SPRAVATO® (Esketamine) Nasal Spray
SPRAVATO® is an FDA-approved esketamine nasal spray for certain adults with treatment-resistant depression. It acts on the brain's glutamate system, providing a different approach from many traditional antidepressants.
Treatment takes place in a certified healthcare setting. Patients self-administer the medication under clinical supervision, with medical monitoring after every dose.
How do I begin SPRAVATO® treatment?
- Speak with our team about your symptoms and treatment history.
- Complete a clinical evaluation to determine eligibility.
- Review insurance or available payment options.
- Coordinate prescription, specialty pharmacy delivery, and scheduling.
- Attend supervised treatment sessions and follow-up evaluations.
Insurance coverage, treatment locations, and appointment availability must be confirmed. Clinical eligibility and monitoring requirements apply.